A U.K. trade group has rebuked Leo Pharma over an incident in which a company ma...
The FDA discovered another troubled plant run by Intas Pharmaceuticals, a generi...
Getting rid of bias in clinical calculators isn't as simple as taking race out o...
“I think the trend is moving away from BMI, but these entrenched issues don’t fa...
Genomic data from the tumors of more than 4,000 dogs is offering insights for tr...
The problem with the new Alzheimer’s drugs isn’t the drugs.
On Thursday, the FDA's scientific advisers said the next round of Covid vaccines...
In the latest edition of STAT's Health Tech newsletter: a chatbot that's cautiou...
Can unicorns survive without data? Did biotech get over its skis? And what is go...
To combat the opioid crisis, the White House is convening naloxone makers, but l...
Claims that livestock are raised without antibiotics "must be backed by empirica...
In 2021, there were about 2,900 suicides in youths ages 10 to 19, and 4,200 in 2...
Expanded access to a new Alzheimer’s drug is unlikely to happen quickly even if ...
PDS Biotech's disclosures have been opaque and confusing — and maybe on purpose,...
Julius Thomas: “It's important for people to understand that there's not a statu...
The CDC may be about to undergo a paradigm shift with the anticipated appointmen...
